Can ADCs broaden the treatment landscape of metastatic ER+/HER2- breast cancer resistant to CDK4/6 inhibition?

ABSTRACT:

SUBMITTER: Van Baelen K 

PROVIDER: S-EPMC10113101 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature